Daiichi Sankyo (OTCMKTS:DSNKY) Hits New 1-Year Low – Here’s What Happened

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKYGet Free Report) shares reached a new 52-week low on Tuesday . The company traded as low as $22.47 and last traded at $22.66, with a volume of 412148 shares traded. The stock had previously closed at $22.65.

Daiichi Sankyo Trading Up 0.0 %

The business has a fifty day moving average of $26.50 and a two-hundred day moving average of $31.47. The firm has a market cap of $43.24 billion and a price-to-earnings ratio of 26.35. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.11 and a current ratio of 2.77.

Daiichi Sankyo (OTCMKTS:DSNKYGet Free Report) last posted its earnings results on Friday, January 31st. The company reported $0.22 earnings per share for the quarter. Daiichi Sankyo had a return on equity of 14.53% and a net margin of 13.62%. As a group, equities analysts expect that Daiichi Sankyo Company, Limited will post 0.73 earnings per share for the current fiscal year.

Daiichi Sankyo Company Profile

(Get Free Report)

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

Recommended Stories

Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.